MDXG Long Call Strategy

MDXG (MiMedx Group, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. Another key product is AmnioFix, a protective, semi-permeable allograft made from dehydrated human amnion/chorion membrane, utilized to aid post-surgical recovery. EpiCord and AmnioCord, both derived from dehydrated human umbilical cord, function as allografts that foster a protective healing environment and are applied in both advanced wound care and surgical recovery contexts.

MDXG (MiMedx Group, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $585.4M, a trailing P/E of 19.01, a beta of 1.46 versus the broader market, a 52-week range of 3.03-7.99, average daily share volume of 1.5M, a public-listing history dating back to 2008, approximately 837 full-time employees. These structural characteristics shape how MDXG stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.46 indicates MDXG has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long call on MDXG?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current MDXG snapshot

As of June 29, 2026, spot at $3.91, ATM IV 25.10%, IV rank 1.37%, expected move 7.20%. The long call on MDXG below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this long call structure on MDXG specifically: MDXG IV at 25.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a MDXG long call, with a market-implied 1-standard-deviation move of approximately 7.20% (roughly $0.28 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MDXG expiries trade a higher absolute premium for lower per-day decay. Position sizing on MDXG should anchor to the underlying notional of $3.91 per share and to the trader's directional view on MDXG stock.

MDXG long call setup

The MDXG long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MDXG near $3.91, the first option leg uses a $3.91 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MDXG chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MDXG shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$3.91N/A

MDXG long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

MDXG long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on MDXG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on MDXG

Long calls on MDXG express a bullish thesis with defined risk; traders use them ahead of MDXG catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

MDXG thesis for this long call

The market-implied 1-standard-deviation range for MDXG extends from approximately $3.63 on the downside to $4.19 on the upside. A MDXG long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current MDXG IV rank near 1.37% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MDXG at 25.10%. As a Healthcare name, MDXG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MDXG-specific events.

MDXG long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MDXG positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MDXG alongside the broader basket even when MDXG-specific fundamentals are unchanged. Long-premium structures like a long call on MDXG are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MDXG chain quotes before placing a trade.

Frequently asked questions

What is a long call on MDXG?
A long call on MDXG is the long call strategy applied to MDXG (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With MDXG stock trading near $3.91, the strikes shown on this page are snapped to the nearest listed MDXG chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are MDXG long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the MDXG long call priced from the end-of-day chain at a 30-day expiry (ATM IV 25.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MDXG long call?
The breakeven for the MDXG long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MDXG market-implied 1-standard-deviation expected move is approximately 7.20%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on MDXG?
Long calls on MDXG express a bullish thesis with defined risk; traders use them ahead of MDXG catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current MDXG implied volatility affect this long call?
MDXG ATM IV is at 25.10% with IV rank near 1.37%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related MDXG analysis